Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)
Public ClinicalTrials.gov record NCT05194540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Phase 3 Trial to Evaluate the Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Subjects With Moderate-to-severe Atopic Dermatitis
Study identification
- NCT ID
- NCT05194540
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- LEO Pharma
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
- Tralokinumab Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2022
- Primary completion
- Jun 5, 2023
- Completion
- Jun 20, 2023
- Last update posted
- Mar 10, 2025
2022 – 2023
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| LEO Pharma Investigator | Birmingham | Alabama | 35205 | — |
| LEO Pharma Investigator | Birmingham | Alabama | 35209 | — |
| LEO Pharma Investigator | Fort Smith | Arkansas | 72916 | — |
| LEO Pharma Investigator | Fountain Valley | California | 92708 | — |
| LEO Pharma Investigator | Fremont | California | 94538 | — |
| LEO Pharma Investigational Site | Inglewood | California | 90301 | — |
| LEO Pharma Investigator | Los Angeles | California | 90025 | — |
| LEO Pharma Investigator | San Diego | California | 92103 | — |
| LEO Pharma Investigator | San Diego | California | 92130 | — |
| LEO Pharma Investigator | Santa Ana | California | 92701 | — |
| LEO Pharma Investigator | Centennial | Colorado | 80111 | — |
| LEO Pharma Investigator | Farmington | Connecticut | 06032 | — |
| LEO Pharma Investigational Site | Hialeah | Florida | 33012 | — |
| LEO Pharma Investigator | Sanford | Florida | 32771 | — |
| LEO Pharma Investigator | Libertyville | Illinois | 60048 | — |
| LEO Pharma Investigator | Overland Park | Kansas | 66210 | — |
| LEO Pharma Investigator | Bangor | Maine | 04401 | — |
| LEO Pharma Investigator | Detroit | Michigan | 48202 | — |
| LEO Pharma Investigator | Portsmouth | New Hampshire | 03801 | — |
| LEO Pharma Investigator | Cortland | New York | 13045 | — |
| LEO Pharma Investigator | Horseheads | New York | 14845 | — |
| LEO Pharma Investigator | Bexley | Ohio | 43209 | — |
| LEO Pharma Investigator | Toledo | Ohio | 43617 | — |
| LEO Pharma Investigator | Tulsa | Oklahoma | 74136 | — |
| LEO Pharma Investigator | Portland | Oregon | 97210 | — |
| LEO Pharma Investigator | Dallas | Texas | 75225 | — |
| LEO Pharma Investigator | Frisco | Texas | 75034 | — |
| LEO Pharma Investigator | San Antonio | Texas | 78218 | — |
| LEO Pharma Investigator | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05194540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05194540 live on ClinicalTrials.gov.